Retinitis pigmentosa program (Perceive Biotherapeutics)

N/A

Report date: 2025/01/26 16:26:55
NME

Base Information

Drug NameRetinitis pigmentosa program (Perceive Biotherapeutics)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsRetinitis Pigmentosa
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesPerceive Biotherapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesPerceive Biotherapeutics Inc
Inactive CompaniesN/A
Active IndicationsRetinitis Pigmentosa
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A